FDA Inspection 1256421 — Oklahoma Blood Institute Southwest
The FDA completed an inspection of Oklahoma Blood Institute Southwest on Dec 5, 2024 in Lawton, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 5, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lawton, OK (United States)